Market Analysis on Companion Animal Pharmaceuticals Industry – Insights for Corporate Strategy and R&D
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Companion Animal Pharmaceuticals Market from 2024 to 2025?
In recent times, the companion animal pharmaceuticals market has experienced robust growth. The market valuation is projected to increase from $16.49 billion in 2024 to $17.9 billion in 2025, with an 8.5% compound annual growth rate (CAGR). Growth in the previous period is attributable to the humanization of pets, preventive health care initiatives, an increase in pet insurance, changes in lifestyle and urbanization, concerns over zoonotic diseases, and improved accessibility to veterinary healthcare.
What Is the Projected Market Size of the Companion Animal Pharmaceuticals Market?
The market for companion animal pharmaceuticals is predicted to witness a swift expansion in the upcoming years, reaching a size of $26.52 billion in 2029, with a compound annual growth rate (CAGR) of 10.3%. The driving factors for this growth over the prediction period include the development of personalized pharmaceutical treatments for pets, the rise of telehealth and remote-based veterinary services, attention towards nutrition and nutraceuticals, incorporation of one health initiatives, and the growth of veterinary diagnostic services. Key trends expected within the forecast period involve progress in veterinery medicine, specialized therapeutics for aging pets, adherence to regulatory rules and safety standards, and collaborations and partnerships.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7983&type=smp
Who are the Major Competitors in the Companion Animal Pharmaceuticals Market Outlook?
Major companies operating in the companion animal pharmaceuticals market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International
What Is Fueling Growth in the Companion Animal Pharmaceuticals Market?
The surge in zoonotic diseases is poised to stimulate the expansion of the companion animal pharmaceuticals market in the future. Zoonotic diseases can naturally spread from vertebrate animals to people or from humans to animals. To tackle zoonotic diseases and minimize transmission possibilities, the pharmaceutical sector is adopting advanced tactics consistent with a unified set of health principles. As per a report by the European Centre for Disease Prevention and Control published in December 2022, Campylobacteriosis continued to be the most widespread zoonotic disease in Sweden, with a significant increase in reported cases, reaching 127,840 in 2022. Poultry, including chicken and turkey, was responsible for most Campylobacteriosis cases reported. Following this, Salmonella, the second most common zoonosis, affected 60,050 people. Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) trailed behind Campylobacteriosis and Salmonellosis as the most commonly reported zoonotic illnesses. Consequently, the rising incidence of zoonotic diseases is fuelling the growth of the companion animal pharmaceuticals market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=7983&type=smp
Which Companion Animal Pharmaceuticals Market Segments Are Growing the Fastest?
The companion animal pharmaceuticals market covered in this report is segmented –
1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals
2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies
Subsegments:
1)By Dogs: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
2) By Cats: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
3) By Horses: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
4) By Other Companion Animals: Vaccines, Antiparasitic, Other Therapeutics
Which Industry Trends Are Shaping the Future of the Companion Animal Pharmaceuticals Market?
The increasing uptake of big data technologies is a significant trend that is gaining traction in the companion animal pharmaceuticals sector. Major players in the companion animal pharmaceutical market are focusing on creating innovative technological solutions to cement their market standing. For instance, in April 2022, Elanco Animal Health Incorporated, a firm based in the US that is active in the companion animal pharmaceutical sector, collaborated with Ginkgo Bioworks, another US-based firm in the same field, to inaugurate BiomEdit, a company specializing in microbiome innovation. This new venture aims to spearhead innovation in animal health by providing unique probiotics and other related animal pharmaceuticals, like medicated feed additives, nutritional health products, therapies for both livestock and pets, and biosecurity technologies for monitoring animal diseases.
Access The Full Report Here:
Which Countries Are Leading the Companion Animal Pharmaceuticals Market?
North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7983
This Report Delivers Insight On:
1. How big is the companion animal pharmaceuticals market, and how is it changing globally?
2. Who are the major companies in the companion animal pharmaceuticals market, and how are they performing?
3. What are the key opportunities and risks in the companion animal pharmaceuticals market right now?
4. Which products or customer segments are growing the most in the companion animal pharmaceuticals market?
5. What factors are helping or slowing down the growth of the companion animal pharmaceuticals market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model